Key Metrics
2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Q4
Oncology
SJR
- Q3 Oncology
- Q3 Hematology
- Q4 Cancer Research
- Q3 Radiology, Nuclear Medicine and Imaging
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.47
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Cancer
- Overall survival
- Lung cancer
- Acetaminophen
- Immunotherapy
- Chemotherapy
- Breast cancer
- Darkness
- Mutational analysis
- Hematopoietic stem cell transplantation
- Dysphagia
- Toxicity
- Diffuse large B-cell lymphoma
- Cell therapy
- Questionnaire
- Editorial board
- Pain management
- Osteosarcoma
- Immune checkpoint inhibitors
- Toxicity profile
Journal Specifications
| Overview | |
| Publisher | ELSEVIER MASSON, CORPORATION OFFICE |
| Language | French |
| Frequency | Monthly |
| General Details | |
| Language | French |
| Frequency | Monthly |
| Publication Start Year | 1908 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Bulletin du Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Prise en charge des LAM chez les sujets âgés
- 1 Apr 23
- Bulletin du Cancer
-
Full paper
Editorial board
- 1 Apr 23
- Bulletin du Cancer
-
Full paper
Tumeurs de Bellini et carcinomes médullaires rénaux à l’ère des nouvelles thérapies
- 1 Apr 23
- Bulletin du Cancer
-
Full paper
Contents
- 1 Apr 23
- Bulletin du Cancer
-
Full paper
Sommaire
- 1 Apr 23
- Bulletin du Cancer
-
Full paper
Remerciements
- 1 Dec 14
- Bulletin du Cancer
Scite analysis
Powered by scite_
3.5k articles received 4.8k citations see all
- 164 Supporting
- 4,136 Mentioning
- 29 Contrasting
Editorial notices
- 1 Retractions
- 7 Withdrawals
- 0 Corrections
- 14 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
12%
4 to 6 months
50%
7 to 9 months
25%
Above 9 months
14%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Bulletin du Cancer been actively publishing?
Bulletin du Cancer has been in operation since 1908 till date.
What is the publishing frequency of Bulletin du Cancer ?
Bulletin du Cancer published with a Monthly frequency.
How many articles did Bulletin du Cancer publish last years ?
In 2023, Bulletin du Cancer published 5 articles.
What is the eISSN & pISSN for Bulletin du Cancer ?
For Bulletin du Cancer,eISSN is 1769-6917 and pISSN is0007-4551.
What is Citescore for Bulletin du Cancer ?
Citescore for Bulletin du Cancer is 2.
What is SNIP score for Bulletin du Cancer ?
SNIP score for Bulletin du Cancer is 0.47.
What is the SJR for Bulletin du Cancer ?
SJR for Bulletin du Cancer is Q4.
Who is the publisher of Bulletin du Cancer ?
ELSEVIER MASSON, CORPORATION OFFICE is the publisher of Bulletin du Cancer.